Literature DB >> 24133601

Primary bone carcinosarcoma of the fibula with chondrosarcoma and squamous cell carcinoma components.

Mitsuaki Ishida1, Narihito Kodama, Yoshinori Takemura, Muneo Iwai, Keiko Yoshida, Akiko Kagotani, Yoshitaka Matsusue, Hidetoshi Okabe.   

Abstract

Carcinosarcoma is defined as a malignant neoplasm that is composed of both carcinomatous and sarcomatous components. The occurrence of carcinosarcoma in the bone is extremely rare. In this report, we describe the third documented de novo case of carcinosarcoma of the bone. A 59-year-old Japanese female presented with a painful tumor in her right lower leg. Plane radiography revealed an osteolytic destructive lesion with periosteal reaction and mineralization in the right fibula. Resection of the fibula tumor was performed under a clinical diagnosis of chondrosarcoma. Histopathological study revealed that the tumor was comprised of three components. The main component was proliferation of small round to short spindle cells (approximately 50%), and the remaining components were chondrosarcoma (30%) and squamous cell carcinoma (20%). Immunohistochemically, SOX9 was expressed in the small round to spindle cells and chondrosarcoma component, and p63 and p40 were expressed in all three components. Accordingly, an ultimate diagnosis of carcinosarcoma of the bone was made. The clinicopathological analysis of carcinosarcoma of the bone revealed that this type of tumor affects the middle-aged to elderly persons and occurs in the long bone. All three de novo cases had chondrosarcoma and squamous cell carcinoma components. One of the 3 patients died of the disease. The histogenesis of carcinosarcoma of the bone remains a matter of controversy, although a multpotential stem cell theory has been proposed. Additional studies are required to clarify the clinical behavior and histogenesis of carcinosarcoma of the bone.

Entities:  

Keywords:  Carcinosarcoma; bone; chondrosarcoma; squamous cell carcinoma

Mesh:

Year:  2013        PMID: 24133601      PMCID: PMC3796245     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  28 in total

1.  Primary bone carcinosarcoma: chondrosarcoma and squamous cell carcinoma with keratin pearl formation.

Authors:  Junichi Shiraishi; Makio Mukai; Hiroo Yabe; Rie Shibata; Taketo Yamada; Keiko Miura; Ukei Anazawa; Hideo Morioka; Michiie Sakamoto
Journal:  Pathol Int       Date:  2005-08       Impact factor: 2.534

2.  Gastric carcinosarcoma: A case report and review of the literature.

Authors:  Roberto Cirocchi; Stefano Trastulli; Jacopo Desiderio; Veronica Grassi; Ivan Barillaro; Alberto Santoro; Carlo Boselli; Nicola Avenia; Giuseppe Noya; Angelo DE Sol
Journal:  Oncol Lett       Date:  2012-04-27       Impact factor: 2.967

Review 3.  Polyhistioma: a malignant tumor of bone and extraskeletal tissues.

Authors:  S A Jacobson
Journal:  Cancer       Date:  1977-11       Impact factor: 6.860

4.  Primitive multipotential primary sarcoma of bone.

Authors:  R V Hutter; F W Foote; K C Francis; R S Sherman
Journal:  Cancer       Date:  1966-01       Impact factor: 6.860

5.  p63 immunohistochemical staining is limited in soft tissue tumors.

Authors:  Vickie Y Jo; Christopher D M Fletcher
Journal:  Am J Clin Pathol       Date:  2011-11       Impact factor: 2.493

6.  Osteosarcoma with prominent epithelioid features.

Authors:  H Yoshida; T Yumoto; H Adachi; T Minamizaki; N Maeda; K Furuse
Journal:  Acta Pathol Jpn       Date:  1989-07

7.  Carcinosarcoma of female urethra with melanocytic differentiation.

Authors:  Jun Liu; Hong Wu
Journal:  Int J Clin Exp Pathol       Date:  2011-01-30

8.  Primary multipotential malignant neoplasm of bone: chondrosarcoma associated with squamous cell carcinoma.

Authors:  L L Ling; G C Steiner
Journal:  Hum Pathol       Date:  1986-03       Impact factor: 3.466

Review 9.  Sarcomatoid carcinoma with small cell carcinoma component of the urinary bladder: a case report with review of the literature.

Authors:  Mitsuaki Ishida; Muneo Iwai; Keiko Yoshida; Akiko Kagotani; Hidetoshi Okabe
Journal:  Int J Clin Exp Pathol       Date:  2013-07-15

10.  Giant cell tumor of bone express p63.

Authors:  Brendan C Dickson; Shu-Qiu Li; Jay S Wunder; Peter C Ferguson; Behnam Eslami; Joel A Werier; Robert E Turcotte; Rita A Kandel
Journal:  Mod Pathol       Date:  2008-02-29       Impact factor: 7.842

View more
  5 in total

1.  Skin erythema with leukocytoclastic vasculitis and elastophagocytosis as the presenting features of an underlying myelodysplastic syndrome.

Authors:  Mitsuaki Ishida; Hiroko Okuno; Miyuki Yoshii; Akiko Horinouchi; Ayaka Shirakawa; Ayumi Harada; Muneo Iwai; Keiko Yoshida; Akiko Kagotani; Takashi Yoshida; Hidetoshi Okabe
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

2.  IgD plasmablastic myeloma: a case report with emphasis on the cytological features.

Authors:  Mitsuaki Ishida; Keiko Hodohara; Hiroko Okuno; Miyuki Yoshii; Akiko Horinouchi; Ayaka Shirakawa; Ayumi Harada; Muneo Iwai; Keiko Yoshida; Akiko Kagotani; Takashi Yoshida; Hidetoshi Okabe
Journal:  Int J Clin Exp Pathol       Date:  2014-02-15

Review 3.  Concomitant occurrence of IgG4-related pleuritis and periaortitis: a case report with review of the literature.

Authors:  Mitsuaki Ishida; Keiko Hodohara; Aya Furuya; Aya Fujishiro; Hiroko Okuno; Miyuki Yoshii; Akiko Horinouchi; Ayaka Shirakawa; Ayumi Harada; Muneo Iwai; Keiko Yoshida; Akiko Kagotani; Takashi Yoshida; Hidetoshi Okabe
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

4.  Sebaceous carcinoma associated with Bowen's disease: a case report with emphasis on the pathogenesis of sebaceous carcinoma.

Authors:  Mitsuaki Ishida; Muneo Iwai; Keiko Yoshida; Akiko Kagotani; Hidetoshi Okabe
Journal:  Int J Clin Exp Pathol       Date:  2013-11-15

5.  Primary cutaneous B-cell lymphoma with abundant reactive gamma/delta T-cells within the skin lesion and peripheral blood.

Authors:  Mitsuaki Ishida; Muneo Iwai; Keiko Yoshida; Akiko Kagotani; Hidetoshi Okabe
Journal:  Int J Clin Exp Pathol       Date:  2014-02-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.